COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,635 Articles (22,913 medRxiv, 8,722 bioRxiv)

Most recent first Previous |  Page 2379: Articles 23781-23790  | Next

Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells
Parker, R., Partridge, T., Wormald, C., Kawahara, R., Stalls, V., Aggelakopoulou, M., Parker, J., Powell Doherty, R., Ariosa-Morejon, Y., Lee, E., Saunders, K., Haynes, B. F., Acharya, P., Thaysen-Andersen, M., Borrow, P., Ternette, N.
10.1101/2020.08.19.255901 — Posted: 2020-08-20
Exploring G and C-quadruplex structures as potential targets against the severe acute respiratory syndrome coronavirus 2
Belmonte Reche, E., Serrano-Chacon, I., Gonzalez, C., Gallo, J., Banobre-Lopez, M.
10.1101/2020.08.19.257493 — Posted: 2020-08-20
Air pollution, SARS-CoV-2 transmission, and COVID-19 outcomes: A state-of-the-science review of a rapidly evolving research area
Bhaskar, A., Chandra, J., Braun, D., Cellini, J., Dominici, F.
10.1101/2020.08.16.20175901 — Posted: 2020-08-20
Covid19data.website
malouche, d.
10.1101/2020.08.14.20174995 — Posted: 2020-08-20 Discussion: Onsite
COVID-19: Effectiveness of Non-Pharmaceutical Interventions in the United States before Phased Removal of Social Distancing Protections Varies by Region
Pan, W., Tyrovolas, S., Gine Vazquez, I., Raj, R., Fernandez, D., Zaitchik, B., Lantos, P., Woods, C. W.
10.1101/2020.08.18.20177600 — Posted: 2020-08-20
The first thousands of cases of coronavirus disease 2019 (COVID-19) in Algeria: some risk factors
TALEB, S. M., BOUSSAKTA, M. A.
10.1101/2020.08.17.20176396 — Posted: 2020-08-20
RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study
Walsh, E. E., Frenck, R., Falsey, A. R., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Neuzil, K., Mulligan, M. J., Bailey, R., Swanson, K. A., Li, P., Koury, K., Kalina, W., Cooper, D., Fontes-Garfias, C., Shi, P.-Y., Türeci, O., Thompkins, K. R., Lyke, K. E., Raabe, V., Dormitzer, P. R., Jansen, K. U., Sahin, U., Gruber, W. C.
10.1101/2020.08.17.20176651 — Posted: 2020-08-20
Identification of potential key genes for SARS-CoV-2 infected human bronchial organoids based on bioinformatics analysis
Gu, H., Yuan, G.
10.1101/2020.08.18.256735 — Posted: 2020-08-19
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
Guebre-Xabier, M., Patel, N., Tian, J.-H., Zhou, B., Maciejewski, S., Lam, K., Portnoff, A. D., Massare, M. J., Frieman, M. B., Piedra, P. A., Ellingsworth, L. R., Glenn, G., Smith, G.
10.1101/2020.08.18.256578 — Posted: 2020-08-19
SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in Cells
Dominguez Andres, A., Feng, Y., Campos, A. R., Yin, J., Yang, C.-C., James, B., Murad, R., Kim, H., Deshpande, A. J., Gordon, D. E., Krogan, N. J., Pippa, R., Ronai, Z. A.
10.1101/2020.08.18.256776 — Posted: 2020-08-19 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).